SI2066327T1 - Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors - Google Patents

Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors

Info

Publication number
SI2066327T1
SI2066327T1 SI200731143T SI200731143T SI2066327T1 SI 2066327 T1 SI2066327 T1 SI 2066327T1 SI 200731143 T SI200731143 T SI 200731143T SI 200731143 T SI200731143 T SI 200731143T SI 2066327 T1 SI2066327 T1 SI 2066327T1
Authority
SI
Slovenia
Prior art keywords
class
inhibitors
combination
histone
iib
Prior art date
Application number
SI200731143T
Other languages
Slovenian (sl)
Inventor
Janine Arts
Peter Willem Jan Hellemans
Michel Marie Francois Janicot
Martin John Page
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Priority claimed from PCT/EP2007/059518 external-priority patent/WO2008031817A2/en
Publication of SI2066327T1 publication Critical patent/SI2066327T1/en

Links

SI200731143T 2006-09-15 2007-09-11 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors SI2066327T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06120726 2006-09-15
US91589507P 2007-05-03 2007-05-03
PCT/EP2007/059518 WO2008031817A2 (en) 2006-09-15 2007-09-11 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors
EP07803397A EP2066327B1 (en) 2006-09-15 2007-09-11 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors

Publications (1)

Publication Number Publication Date
SI2066327T1 true SI2066327T1 (en) 2013-04-30

Family

ID=41040414

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200731143T SI2066327T1 (en) 2006-09-15 2007-09-11 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors

Country Status (12)

Country Link
CN (1) CN101516374B (en)
BR (1) BRPI0716992A2 (en)
DK (1) DK2066327T3 (en)
ES (1) ES2399670T3 (en)
ME (1) ME01514B (en)
NZ (1) NZ575030A (en)
PT (1) PT2066327E (en)
RS (1) RS52638B (en)
SG (1) SG177219A1 (en)
SI (1) SI2066327T1 (en)
UA (1) UA97249C2 (en)
ZA (1) ZA200901818B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957066B2 (en) * 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
CN115487191B (en) * 2016-02-22 2024-05-14 中国科学院上海巴斯德研究所 Quisinostat, a novel high-efficiency antimalarial drug
AU2017298473A1 (en) * 2016-07-20 2019-01-24 The Trustees Of Columbia University In The City Of New York Histone acetyltransferase activators and compositions and uses thereof
CN114409638B (en) * 2022-02-09 2023-02-14 深圳大学 Histone deacetylase 8 selective degradation agent, preparation method and application thereof in antitumor activity
CN115028678A (en) * 2022-07-08 2022-09-09 杭州医学院 Bifunctional molecule based on BCR-ABL protein degradation induced by VHL ligand and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG156687A1 (en) * 2004-07-28 2009-11-26 Janssen Pharmaceutica Nv Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase

Also Published As

Publication number Publication date
PT2066327E (en) 2013-02-06
ME01514B (en) 2014-04-20
ZA200901818B (en) 2010-05-26
RS52638B (en) 2013-06-28
ES2399670T3 (en) 2013-04-02
UA97249C2 (en) 2012-01-25
NZ575030A (en) 2012-07-27
BRPI0716992A2 (en) 2013-09-17
CN101516374A (en) 2009-08-26
CN101516374B (en) 2013-04-24
SG177219A1 (en) 2012-01-30
DK2066327T3 (en) 2013-02-11

Similar Documents

Publication Publication Date Title
HK1136770A1 (en) Histone deacetylase inhibitors with combined activity on class-i and class- iib histone deacetylases in combination with proteasome inhibitors
HK1133199A1 (en) Histone deacetylase and tubulin deacetylase inhibitors
ZA200905060B (en) Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
HK1161583A1 (en) Deacetylase inhibitors and uses thereof
HK1220179A1 (en) Inhibitors of histone deacetylase
EP1973872A4 (en) Inhibitors of histone deacetylase and prodrugs thereof
EP1940805A4 (en) Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
EP1991247A4 (en) Bifunctional histone deacetylase inhibitors
HK1135902A1 (en) Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors
EP1991951A4 (en) Portable point of sale systems and methods
ZA200800901B (en) Histone deacetylase inhibitors
EP1945617A4 (en) Histone deacetylase inhibitors with aryl-pyrazolyl motifs
IL193458A0 (en) Histone deacetylase inhibitors
EP1771167A4 (en) Histone deacetylase inhibitors
IL205241A0 (en) Histone deacetylase inhibitors
IL198263A0 (en) Hydroxamates as inhibitors of histone deacetylase
EP1991226A4 (en) Inhibitors of histone deacetylase
EP2308868A4 (en) Histone deacetylase inhibitors and uses thereof
IL214244A (en) Histone deacetylase inhibitors and their use in therapy
EP2208721A4 (en) Histone deacetylase inhibitor, composition and use thereof
EP1784386A4 (en) Histone deacetylase inhibitors
EP2089354A4 (en) Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same
EP1784194A4 (en) Histone deacetylase inhibitors
EP2231596A4 (en) Histone deacetylase inhibitors
ZA200901818B (en) Histone deacetylase inhibitors with combined activity on class-I and class-IIB histone deacetylases in combination with proteasome inhibitors